Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Biofrontera Inc (BFRI)

Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Beam Therapeutics Inc. (BEAM) Reports Q1 Loss, Tops Revenue Estimates Zacks - Wed May 10, 2023

Beam Therapeutics Inc. (BEAM) delivered earnings and revenue surprises of 2.21% and 67.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

BEAM : 23.13 (+1.80%)
BFRI : 1.7200 (-3.91%)
Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates Zacks - Fri May 5, 2023

Editas (EDIT) delivered earnings and revenue surprises of 10.13% and 97.42%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

EDIT : 5.67 (+0.89%)
BFRI : 1.7200 (-3.91%)
Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Misses Revenue Estimates Zacks - Thu May 4, 2023

Kymera Therapeutics, Inc. (KYMR) delivered earnings and revenue surprises of -1.45% and 30.28%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

KYMR : 37.40 (+3.03%)
BFRI : 1.7200 (-3.91%)
Biofrontera Inc. (BFRI) Reports Q3 Loss, Tops Revenue Estimates Zacks - Mon Nov 14, 2022

Biofrontera Inc. (BFRI) delivered earnings and revenue surprises of 28.13% and 0.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

BFRI : 1.7200 (-3.91%)
VBLT : 5.4600 (-8.77%)
Entera Bio Ltd. (ENTX) Reports Q3 Loss, Misses Revenue Estimates Zacks - Thu Nov 10, 2022

Entera Bio Ltd. (ENTX) delivered earnings and revenue surprises of 31.25% and 88.57%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ENTX : 2.16 (+3.35%)
BFRI : 1.7200 (-3.91%)
Curis (CRIS) Reports Q3 Loss, Misses Revenue Estimates Zacks - Wed Nov 9, 2022

Curis (CRIS) delivered earnings and revenue surprises of 17.65% and 6.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CRIS : 16.36 (-0.91%)
BFRI : 1.7200 (-3.91%)
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand FinancialNewsMedia - Tue Oct 4, 2022

Palm Beach, FL – October 4, 2022 – FinancialNewsMedia.com News Commentary –  The laser therapy market has been having a very health growth trend in recent years and is expected to continue through...

PIXY : 1.9100 (+8.52%)
EW : 85.25 (+0.22%)
BFRI : 1.7200 (-3.91%)
LITE : 44.74 (+1.02%)
CUTR : 2.53 (-1.56%)
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand PR Newswire - Tue Oct 4, 2022

/PRNewswire/ -- The laser therapy market has been having a very health growth trend in recent years and is expected to continue through the coming years....

PIXY : 1.9100 (+8.52%)
EW : 85.25 (+0.22%)
BFRI : 1.7200 (-3.91%)
LITE : 44.74 (+1.02%)
CUTR : 2.53 (-1.56%)
Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted to Biofrontera Bioscience GmbH Globe Newswire - Mon Aug 1, 2022

Patent Improves Differentiated Profile of Ameluz-PDT by Expected Reduced Pain Intensity while Maintaining Efficacy WOBURN, Mass., Aug. 01, 2022 (GLOBE...

BFRI : 1.7200 (-3.91%)
BFRIW : 0.0600 (unch)
Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement Globe Newswire - Wed Jul 27, 2022

WOBURN, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0600 (unch)
BFRI : 1.7200 (-3.91%)

Barchart Exclusives

2 Small-Cap Stocks With 40% to 60% Upside Barchart - Sat May 4, 2:45PM CDT
Wall Street believes these two growth stocks will soar, driven by the demand for their products. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot